“Clinician- and Patient-Reported Outcomes With Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study)”. 2023. SKIN The Journal of Cutaneous Medicine 7 (3): 771-87. https://doi.org/10.25251/skin.7.3.3.